NRX Pharmaceuticals Inc (NRXP) Stock Price

3.50 ▲ +0.10 (+2.94%)
Open: 3.36 Vol: 11.45K Day's range: 3.36 - 3.59 Sep 14, 15:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
NRXP Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY NEUTRAL
  5 mins 30 mins Hourly Daily Weekly
MA5 3.48▲ 3.50▲ 3.50▲ 3.43▲ 3.50▲
MA10 3.48▲ 3.49▲ 3.46▲ 3.44▲ 3.55▼
MA20 3.50▲ 3.45▲ 3.43▲ 3.47▲ 3.66▼
MA50 3.49▲ 3.43▲ 3.44▲ 3.63▼ 2.88▲
MA100 3.45▲ 3.44▲ 3.47▲ 3.60▼ 2.67▲
MA200 3.43▲ 3.47▲ 3.42▲ 2.88▲ 3.86▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.002▼ 0.004▲ 0.012▲ 0.007▲ -0.081▼
RSI 53.044▲ 60.862▲ 60.716▲ 50.703▲ 52.757▲
STOCH 45.455     59.711     77.729     32.728     35.256    
WILL %R -9.091▲ -39.130     -39.130     -51.351     -62.637    
CCI 35.035     24.823     66.243     11.931     -47.306    
Latest Filters Detected On NRXP
▲ RSI&VOL $NRXP RSI Cross Up and Volume Set Alert
RSI $NRXP RSI(14) Crossed Above 50 Set Alert
MA $NRXP Price Crossed Above MA(26) Set Alert
MA $NRXP Price Crossed Above MA(13) Set Alert
MA $NRXP Price Crossed Above MA(7) Set Alert
CDL $NRXP Engulfing Candlestick Pattern Detected Set Alert
NRX Pharmaceuticals Inc News
GeNeuro wins European patent for ALS drug candidate GNK-301
Monday, September 14, 2026 04:19 AM
GeNeuro, Inc., a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), announced it has been awarded a European patent (EP 3 570 878 B1) for GNK-301, a monoclonal antibody drug candidate targeting ...
GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)
Monday, September 14, 2026 03:59 AM
Invention is based on the discovery that ALS may be caused by reactivation of Human Endogenous Retrovirus K (HERV K) Envelope protein (K Env), already coded in the “dark genome” of all people. K Env ...
NRx Pharmaceuticals, Inc.: NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System
Friday, September 11, 2026 06:06 AM
HOPE is the first Interventional Psychiatry network to deploy Zeta Surgical's newly FDA-cleared TMS Robotic System; the HOPE clinical team is completing orientation and training at Zeta Surgical's hea ...
NRXP historical stock data
date open high low close volume
14/09/26 3.36 3.60 3.36 3.50 1,179,856
11/09/26 3.44 3.44 3.37 3.40 356,231
10/09/26 3.36 3.45 3.32 3.40 480,116
09/09/26 3.48 3.52 3.34 3.37 520,713
08/09/26 3.50 3.54 3.42 3.47 705,974
04/09/26 3.43 3.50 3.39 3.49 487,720
03/09/26 3.48 3.50 3.425 3.43 237,362
02/09/26 3.46 3.50 3.38 3.46 418,341
01/09/26 3.45 3.51 3.42 3.44 392,760
31/08/26 3.52 3.545 3.43 3.48 427,013
Quote Details
52wk Low:1.62
52wk High:5.055
Vol:11.45K
Avg Vol(3m):15.9M
1Y Chng:+6.06%
1M Chng:+8.02%
Add to Watch List
More Information
Index US Composite
Market Cap. 147.21M